2022
DOI: 10.1007/s11255-022-03391-2
|View full text |Cite
|
Sign up to set email alerts
|

Lower serum magnesium is a predictor of left ventricular hypertrophy in patients on dialysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
1

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 41 publications
0
1
1
Order By: Relevance
“…injection of a magnesium salt has already been shown to improve cardiac hypertrophy in a mouse model of myocardial fibrosis [ 47 ]. Even though numerous studies highlight the evidence of hypomagnesemia in CKD [ 1 , 46 , 48 ], we did not detect significant changes in the serum magnesium levels in any group. Thus, we cannot conclude on the precise impact of hypomagnesemia here.…”
Section: Discussioncontrasting
confidence: 95%
See 1 more Smart Citation
“…injection of a magnesium salt has already been shown to improve cardiac hypertrophy in a mouse model of myocardial fibrosis [ 47 ]. Even though numerous studies highlight the evidence of hypomagnesemia in CKD [ 1 , 46 , 48 ], we did not detect significant changes in the serum magnesium levels in any group. Thus, we cannot conclude on the precise impact of hypomagnesemia here.…”
Section: Discussioncontrasting
confidence: 95%
“…Cardiac hypertrophy is regarded as one hallmark of uremic cardiomyopathy, besides capillary changes and fibrosis [ 45 ]. On the other hand, lower serum magnesium was found to be independently associated with left ventricular hypertrophy in dialysis patients [ 46 ]. An i.p.…”
Section: Discussionmentioning
confidence: 99%